About us
Our Science
Our Focus
For Patients & Families
Working with others
News
Contact
Khondrion features in new video from Catalyze-Group®
find more articles
Clarifying the Phenotypic Spectrum of m.3243A>G: A Proposal for Terminological Precision in PMD
Khondrion Secures up to €5 Million Innovation Credit from Dutch Government plus Additional Funding from Current Investors to Advance Phase 3 Clinical Trial in m.3243A>G Primary Mitochondrial Disease
UMDF and Khondrion Announce The Mito Fund’s Investment in Khondrion to Support Development of One of the Most Advanced Drug Candidates for Primary Mitochondrial Disease
view all articles